In the Canadian context it's a combination of a variety of actors. Most notably you have your university systems, you have your hospital systems, and you have your national agencies that might be related to health innovation strategy.
I would consider targeting investments to areas where we have done fairly well, for instance, in areas of biotech. Canada might actually be a reasonably important player in the era of personalized medicines. In areas like that you'd be leveraging the reality that Canada has a universal publicly funded health care system that allows us to run reasonable clinical trials and collect data on a very large population if trials are run in our country.